Search results
Genentech R&D (gRED) Genentech was founded in 1976, becoming a member of the Roche Group in 2009. Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody ...
Worldwide. This page provides details of all Roche worldwide locations. If you would like to get in touch with us for different types of queries relating to our medications, diagnostic products and Roche services please visit the page. If you have questions about one of our products or would like to raise a or to report a, please get in touch ...
Roche | Solutions. Solutions. Since the founding of our company, we have been developing innovative solutions for a wide range of chronic and life threatening health conditions that continue to revolutionise healthcare. We continue to be committed to developing medicines and diagnostics that improve people’s lives, delivering rapid, broad and ...
Roche has brought many highly effective drugs onto the market and is a world leader in innovative cancer drugs. Other areas include viral infections, metabolic, central nervous system disorders and inflammatory diseases.
Roche Diagnostics France. Le diagnostic in vitro permet d’aider les cliniciens à sélectionner avec confiance les traitements les plus appropriés, au bon moment pour la bonne personne. Précoce, il évite des prises en charge plus lourdes pour les patients et soignants, et aussi plus coûteuses pour le système de santé.
In 2004, Roche set up a research and early development center (Roche R&D Center (China) Ltd.) in Shanghai. It is the first fully owned multinational pharmaceutical R&D center in Shanghai, now known as the Roche Innovation Center Shanghai (RICS). In 2019, a world class new RICS lab building with a total space of 26,000 square meters was ...
Roche Switzerland is a leading pharmaceutical company that creates innovative medicines and diagnostic tests for patients worldwide.
